Illinois’ high school graduation rate has hit a 15-year high, as students continue to show academic growth post-pandemic, ...

Progress in energy and other areas has damped some of the pessimism around global warming. In 2015, the UN predicted ...

"People are literally going to die from it," warns researcher who has tracked the anti-vaccine movement for decades.

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Mark McDermott The Manhattan Beach Unified School District saw across-the-board increases in student performance, as measured ...

Two weeks into the new school year, Principal Sherree Lewis-DeVaughn eagerly showed off improvements to 135th Elementary ...

Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery and significantly reduced systematic ...

Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC: Rahway, New Jersey Wednesday, October 29, 2025, ...

Wayfair Inc. ( W) Q3 2025 Earnings Call October 28, 2025 8:00 AM EDT Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like ...

Despite the scepticism about renewables in Washington, falling prices for new panels are making a compelling business case ...

Interstitial Lung Disease (ILD): In the PHAROS trial, 1 patient (1%) receiving MEKTOVI with BRAFTOVI developed pneumonitis. Assess new or progressive unexplained pulmonary symptoms or findings for ...

First Phase 3 study (MajesTEC-3) of an investigational combination to show benefit in PFS and OS in relapsed/refractory multiple myeloma as early as second line ...